ZA923069B - Hepatitis b virus surface proteins with reduced host carbohydrate content - Google Patents

Hepatitis b virus surface proteins with reduced host carbohydrate content

Info

Publication number
ZA923069B
ZA923069B ZA923069A ZA923069A ZA923069B ZA 923069 B ZA923069 B ZA 923069B ZA 923069 A ZA923069 A ZA 923069A ZA 923069 A ZA923069 A ZA 923069A ZA 923069 B ZA923069 B ZA 923069B
Authority
ZA
South Africa
Prior art keywords
hbv
surface proteins
hepatitis
carbohydrate content
particles
Prior art date
Application number
ZA923069A
Other languages
English (en)
Inventor
Peter J Kniskern
J Kniskern Peter
Arpi Hagopian
Hagopian Arpi
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA923069B publication Critical patent/ZA923069B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
ZA923069A 1991-04-29 1992-04-28 Hepatitis b virus surface proteins with reduced host carbohydrate content ZA923069B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69292491A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
ZA923069B true ZA923069B (en) 1992-12-30

Family

ID=24782605

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923069A ZA923069B (en) 1991-04-29 1992-04-28 Hepatitis b virus surface proteins with reduced host carbohydrate content

Country Status (25)

Country Link
US (1) US5614384A (fr)
EP (1) EP0516286B1 (fr)
JP (1) JP2637877B2 (fr)
KR (1) KR920019373A (fr)
CN (1) CN1067680A (fr)
AT (1) ATE215987T1 (fr)
AU (1) AU650530B2 (fr)
BG (1) BG61700B1 (fr)
CA (1) CA2067290A1 (fr)
CZ (1) CZ282769B6 (fr)
DE (1) DE69232541D1 (fr)
FI (1) FI934650A (fr)
HU (1) HUT69149A (fr)
IE (1) IE921385A1 (fr)
IL (1) IL101651A0 (fr)
LT (1) LT3367B (fr)
MX (1) MX9201970A (fr)
NO (1) NO933897L (fr)
NZ (1) NZ242487A (fr)
PL (1) PL171485B1 (fr)
SG (1) SG55152A1 (fr)
SK (1) SK118193A3 (fr)
WO (1) WO1992019741A1 (fr)
YU (1) YU45492A (fr)
ZA (1) ZA923069B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
YU30495A (sh) * 1994-05-16 1997-12-05 Merck & Co. Inc. Postupak za dobijanje hbv površinskih proteina
US6696251B1 (en) * 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6300065B1 (en) * 1996-05-31 2001-10-09 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
AU2212100A (en) * 1998-12-23 2000-07-12 Merck & Co., Inc. Improved recombinant hepatitis b surface antigen
KR100604994B1 (ko) 2004-01-30 2006-07-26 한국생명공학연구원 알파1,6-만노실트랜스퍼라제를 코딩하는 한세눌라폴리모르파 기원의 신규 유전자 및 상기 유전자가 결손된한세눌라 폴리모르파 변이주를 이용한 재조합 당단백질생산 방법
CN111187720A (zh) * 2019-12-27 2020-05-22 深圳康泰生物制品股份有限公司 表达肠道病毒71型抗原的重组汉逊酵母的细胞破碎方法及其在制备手足口病疫苗中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
DE3719213C1 (de) * 1987-06-09 1988-05-19 Daimler Benz Ag Bodennahe mehrpolige Stromversorgung fuer spurfuehrbare,gummibereifte,elektrisch antreibbare Fahrzeuge
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
US5135854A (en) * 1987-10-29 1992-08-04 Zymogenetics, Inc. Methods of regulating protein glycosylation
EP0314096B1 (fr) * 1987-10-29 1994-01-12 Zymogenetics, Inc. Méthode de régulation de la glycosylation des protéines
GB8726953D0 (en) * 1987-11-18 1987-12-23 Delta Biotechnology Ltd Yeast expression system
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
ES2109921T3 (es) * 1989-07-25 1998-02-01 Smithkline Beecham Biolog Nuevos antigenos y procedimientos para su preparacion.
CA2022109A1 (fr) * 1989-07-31 1991-02-01 Cheryl A. Schulman Augmentation de l'expression de proteines heterologues dans des hotes recombinants dans un milieu qui n'est pas un milieu de culture
CA2022108A1 (fr) * 1989-07-31 1991-02-01 Cheryl A. Schulman Augmentation de la multiplication et de l'expression de proteines heterologues dans un hote recombinant contenant des mutations dans la bioxynthese de la paroi cellulaire et (ou) de la membrane plasmatique
EP0431679B1 (fr) * 1989-12-05 1994-10-19 Merck & Co. Inc. Procédé de stabilisation de protéines recombinantes de surface du virus de l'hépatitis B à partir de levure
IL101653A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Multiple hepatitis b virus surface proteins which form particles

Also Published As

Publication number Publication date
CA2067290A1 (fr) 1992-10-30
BG61700B1 (bg) 1998-03-31
JPH06141872A (ja) 1994-05-24
EP0516286A1 (fr) 1992-12-02
IL101651A0 (en) 1992-12-30
NO933897D0 (no) 1993-10-28
IE921385A1 (en) 1992-11-04
LTIP462A (en) 1994-10-25
CZ282769B6 (cs) 1997-10-15
SG55152A1 (en) 1998-12-21
KR920019373A (ko) 1992-11-19
WO1992019741A1 (fr) 1992-11-12
CN1067680A (zh) 1993-01-06
HUT69149A (en) 1995-08-28
ATE215987T1 (de) 2002-04-15
AU650530B2 (en) 1994-06-23
BG98187A (bg) 1994-06-30
NO933897L (no) 1993-10-28
SK118193A3 (en) 1994-03-09
CZ227193A3 (en) 1994-04-13
LT3367B (en) 1995-08-25
HU9303064D0 (en) 1994-03-28
DE69232541D1 (de) 2002-05-16
MX9201970A (es) 1992-11-01
US5614384A (en) 1997-03-25
FI934650A0 (fi) 1993-10-21
YU45492A (sh) 1994-06-10
JP2637877B2 (ja) 1997-08-06
FI934650A (fi) 1993-10-21
AU1522292A (en) 1993-03-11
NZ242487A (en) 1994-07-26
PL171485B1 (pl) 1997-05-30
EP0516286B1 (fr) 2002-04-10

Similar Documents

Publication Publication Date Title
LU91388I2 (en) Papillomavirus (humain types 16,18).
HU9202753D0 (en) Process for producing recombinant avain poxvirus and vaccine comprising same
AU576907B2 (en) Oral vaccines comprising live recombinant adenoviruses
IL101651A0 (en) Hepatitis b virus surface proteins with reduced host carbohydrate content
ATE243755T1 (de) Rekombinente adenoviren-impfstoffe
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
YU45292A (sh) Različiti površinski proteini hepatitis b virusa koji obrazuju čestice
CA2116355A1 (fr) Mutants infectieux du virus de la rhinotracheite bovine et vaccins
CA2105277A1 (fr) Souche de virus de la vaccine genetiquement modifiee
EP0288198A3 (fr) Production de peptide
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
Perez et al. Synthesis and secretion of the hepatitis B surface antigen in mammalian cells.
Tron Hepatitis B virus recombinant vaccines: achievement and progress
YU30495A (sh) Postupak za dobijanje hbv površinskih proteina
CA2558659A1 (fr) Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie